Reduced-volume bioburden testing represents a practical and defensible approach for low-volume, high-value cell and gene ...

University students attended Biotech Week Boston Campus to learn about career options in a volatile biopharma industry and ...

Sanofi says integrated continuous purification is a “universal solution” for downstream processing as it prepares for ...

Allogeneic cell therapies offer scalability but require expanded infrastructure to build a viable commercial foundation ...

Examine the use of CHT™ XT Media, a ceramic hydroxyapatite mixed-mode resin, to facilitate purification of various large ...

Dan is currently a trade media relations expert at Sartorius, and he formerly led the news domain of Bioprocess International ...

Drug sponsors seek to capitalize on opportunities created by streamlined regulations for biosimilar characterization.

The successful European Medicines Agency inspection is the latest in a string of positive news for the big Chinese biotech ...

The good manufacturing practice (GMP) obligations of a licensed biomanufacturing site do not ease when the closure announcement is made. If anything, they intensify yet must be met by a team whose ...

Biopharmaceutical manufacturing depends on complex biological and separation processes that must operate consistently under strict quality expectations. Upstream operations such as seed train ...

Sanofi announced the inauguration of the Charles Best Building in Toronto, Canada, to support production of the firm’s Fluzone High-Dose influenza vaccine. The company stated in a public release that ...

International contract development and manufacturing organization (CDMO) Samsung Biologics announced the signing of a US$262 million manufacturing agreement with an unnamed European pharmaceutical ...